Perspective Therapeutics extends asset purchase closing deadline to April 30, 2024

Perspective Therapeutics, Inc.

Amendment No. 1 changes the Termination Date under the Asset Purchase Agreement from March 31, 2024 to April 30, 2024.
Agreement is with GT Medical Technologies for sale of assets by Isoray Medical, a wholly owned subsidiary of Perspective Therapeutics.
No other terms of the original December 7, 2023 Asset Purchase Agreement were modified.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Perspective Therapeutics, Inc. amended Amendment No. 1 to Asset Purchase Agreement with GT Medical Technologies, Inc. valued at Termination date extended from March 31, 2024 to April 30, 2024 (effective 2024-03-28).

Action: amendment
Agreement: asset purchase
Counterparty: GT Medical Technologies, Inc.
Value: Termination date extended from March 31, 2024 to April 30, 2024
Effective: 2024-03-28

Exact text from the filing

On March 28, 2024, Perspective Therapeutics, Inc. (the “ Company ”), Isoray Medical, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ Medical ”), and GT Medical Technologies, Inc., a Delaware corporation (“ GT Medical ”) entered into Amendment No. 1 to Asset Purchase Agreement (the “ Amendment ”), which amends the Asset Purchase Agreement entered into by and among the parties on December 7, 2023 (the “ Agreement ”).

View on SEC.gov

419 material agreements filed in the last 30 days. Browse all material agreements →

Perspective Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-010889

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.